Also trades as: IN.TO (TSX) · $vol 0M
INM NASDAQ
InMed Pharmaceuticals Inc.
1W: -3.6%
1M: -1.5%
3M: -17.4%
YTD: +18.8%
1Y: -40.1%
3Y: -90.6%
5Y: -99.8%
$1.33
-0.02 (-1.48%)
Weekly Expected Move ±5.8%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
9 relationships9
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-10-13
Earliest Filing
2025-06-13
Latest Filing
partner: 4
investor: 3
target: 2
Counterparties (Filed by INM)
9 relationshipsCompanies named in INM's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Yorkville | MCGAU | investor | Counterparty to Amendment to Standby Equity Purchase Agreement regarding suspension of registration statement and Black | 2025-06-13 | View |
| YA II PN, LTD. | — | investor | Counterparty to Amendment to Standby Equity Purchase Agreement as identified in Exhibit 10.1. | 2025-06-13 | View |
| YA II PN, LTD | — | investor | Entered into a Standby Equity Purchase Agreement to purchase up to $10 million in common shares. | 2024-12-18 | View |
| H.C. Wainwright & Co., LLC | — | partner | Sales agent for the At-the-Market Offering Agreement amendment. | 2024-06-28 | View |
| Brio Financial Group | — | partner | Agreement to provide senior financial leadership and bookkeeping services including an Interim CFO. | 2022-12-13 | View |
| H.C. Wainwright & Co., LLC | — | partner | Sales agent for the At the Market Offering Agreement | 2022-04-07 | View |
| BayMedica, LLC | — | target | Target company in the merger, formerly known as InMed LLC | 2021-10-13 | View |
| BayMedica, Inc. | — | target | Target company in the merger, parent of BayMedica, LLC | 2021-10-13 | View |
| BM REP, LLC | — | partner | Stockholder representative for BayMedica stockholders | 2021-10-13 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-18 | Delisting Notice; Other Events; Exhibits | View | |
| 2026-07-22 | Regulation FD; Other Events; Exhibits | View | |
| 2026-07-10 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-06-10 | Other Events; Exhibits | View | |
| 2026-05-19 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-05-19 | Material Agreement; Change in Control; Officer/Director Change; Regulation FD; Exhibits | Agreement | View |
| 2026-05-07 | Regulation FD; Exhibits | View | |
| 2026-04-27 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-04-03 | Other Events; Exhibits | View | |
| 2026-03-30 | Delisting Notice; Exhibits | View | |
| 2026-03-23 | Regulation FD; Exhibits | View | |
| 2026-03-09 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-03-06 | Costs Associated with Exit or Disposal Activities; Regulation FD Disclosure; Financial Statements an | View | |
| 2026-02-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-18 | Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure; Financial Statements | View | |
| 2025-12-15 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-19 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-10-16 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-10-14 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-10-14 | Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR